NIFT-P: Are they indolent tumors? Results of a multi-institutional study.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 02 2018
revised: 03 04 2018
accepted: 09 04 2018
pubmed: 14 11 2018
medline: 15 10 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Encapsulated follicular variant of papillary thyroid carcinoma has recently been reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the basis of its highly indolent behavior, as proposed by an international group of experienced thyroid pathologists. All patients from 9 high-volume endocrine surgery departments who underwent surgery between 2005 and 2015 and whose final surgical pathology revealed noninvasive follicular thyroid neoplasm with papillary-like nuclear features (>10 mm) were included in this study. The primary outcome was to determine the potential for recurrent disease in these patients. Among the 363 patients with noninvasive follicular thyroid neoplasm with papillary-like nuclear features, 76% were female with a median age of 50 years (5-86 years); 345 patients (95%) underwent total thyroidectomy. A total of 65 patients had an associated micropapillary thyroid carcinoma. In the group of 133 patients who underwent prophylactic lymph node dissection (37%), 1 patient had a micrometastasis but with an associated micropapillary thyroid carcinoma. Over a median follow-up period of 5 years, 1 patient with an associated micropapillary thyroid carcinoma had recurrent disease at 6 years. All patients with noninvasive follicular thyroid neoplasm with papillary-like nuclear features without micropapillary thyroid carcinoma had no lymph node metastasis or recurrent disease. We found that noninvasive follicular thyroid neoplasm with papillary-like nuclear features presents with indolent behavior. However, the identification of an associated micropapillary thyroid carcinoma should be carefully evaluated because it could be a factor for lymph node metastasis and/or of recurrence.

Sections du résumé

BACKGROUND
Encapsulated follicular variant of papillary thyroid carcinoma has recently been reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the basis of its highly indolent behavior, as proposed by an international group of experienced thyroid pathologists.
METHODS
All patients from 9 high-volume endocrine surgery departments who underwent surgery between 2005 and 2015 and whose final surgical pathology revealed noninvasive follicular thyroid neoplasm with papillary-like nuclear features (>10 mm) were included in this study. The primary outcome was to determine the potential for recurrent disease in these patients.
RESULTS
Among the 363 patients with noninvasive follicular thyroid neoplasm with papillary-like nuclear features, 76% were female with a median age of 50 years (5-86 years); 345 patients (95%) underwent total thyroidectomy. A total of 65 patients had an associated micropapillary thyroid carcinoma. In the group of 133 patients who underwent prophylactic lymph node dissection (37%), 1 patient had a micrometastasis but with an associated micropapillary thyroid carcinoma. Over a median follow-up period of 5 years, 1 patient with an associated micropapillary thyroid carcinoma had recurrent disease at 6 years. All patients with noninvasive follicular thyroid neoplasm with papillary-like nuclear features without micropapillary thyroid carcinoma had no lymph node metastasis or recurrent disease.
CONCLUSION
We found that noninvasive follicular thyroid neoplasm with papillary-like nuclear features presents with indolent behavior. However, the identification of an associated micropapillary thyroid carcinoma should be carefully evaluated because it could be a factor for lymph node metastasis and/or of recurrence.

Identifiants

pubmed: 30420090
pii: S0039-6060(18)30624-X
doi: 10.1016/j.surg.2018.04.089
pii:
doi:

Substances chimiques

Iodine Radioisotopes 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-16

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Nathalie Chereau (N)

Sorbonne Université, Pitié Salpêtrière Hospital, Paris, France. Electronic address: nathalie.chereau@aphp.fr.

Tristan Greilsamer (T)

Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Institut des maladies de l'Appareil Digestif (IMAD), Hôtel Dieu, CHU Nantes, France.

Eric Mirallié (E)

Clinique de Chirurgie Digestive et Endocrinienne (CCDE), Institut des maladies de l'Appareil Digestif (IMAD), Hôtel Dieu, CHU Nantes, France.

Samira M Sadowski (SM)

University Hospital of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland.

Marc Pusztaszeri (M)

University Hospital of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland.

Frederic Triponez (F)

University Hospital of Geneva and Faculty of Medicine of Geneva, Geneva, Switzerland.

Grégory Baud (G)

Claude Huriez University Hospital, Lille, France.

Francois Pattou (F)

Claude Huriez University Hospital, Lille, France.

Niki Christou (N)

University Hospital of Limoges, France.

Muriel Mathonnet (M)

University Hospital of Limoges, France.

Laurent Brunaud (L)

University of Lorraine, Brabois Hospital, Vandoeuvre-les-Nancy, France.

Nicolas Santucci (N)

University Hospital of Dijon, France.

Pierre Goudet (P)

University Hospital of Dijon, France.

Carole Guérin (C)

University of Aix Marseille, La Conception Hospital, France.

Frédéric Sebag (F)

University of Aix Marseille, La Conception Hospital, France.

Gianluca Donatini (G)

University of Poitiers, Jean Bernard Hospital, France.

Jean-Louis Kraimps (JL)

University of Poitiers, Jean Bernard Hospital, France.

Frédérique Tissier (F)

Sorbonne Université, Department of Pathology,Pitié-Salpêtrière Hospital, Paris, France.

Charlotte Lussey-Lepoutre (C)

Sorbonne Université, Department of Nuclear medicine, Pitié-Salpêtrière Hospital, Paris, France.

Laurence Leenhardt (L)

Sorbonne Université, Thyroid and Endocrine Tumors Unit, Pitié-Salpètrière Hospital, Paris, France.

Fabrice Menegaux (F)

Sorbonne Université, Pitié Salpêtrière Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH